Co-Authors
This is a "connection" page, showing publications co-authored by Albert Prats-Uribe and Carlos Areia.
Connection Strength
0.649
-
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study. BMJ. 2021 05 11; 373:n1038.
Score: 0.236
-
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries. Rheumatology (Oxford). 2021 10 09; 60(SI):SI37-SI50.
Score: 0.061
-
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain. Cancer Epidemiol Biomarkers Prev. 2021 10; 30(10):1884-1894.
Score: 0.060
-
Characteristics and outcomes of 627 044 COVID-19 patients living with and without obesity in the United States, Spain, and the United Kingdom. Int J Obes (Lond). 2021 11; 45(11):2347-2357.
Score: 0.060
-
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study. Rheumatology (Oxford). 2021 07 01; 60(7):3222-3234.
Score: 0.060
-
Thirty-Day Outcomes of Children and Adolescents With COVID-19: An International Experience. Pediatrics. 2021 09; 148(3).
Score: 0.059
-
Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis. Lancet Digit Health. 2021 02; 3(2):e98-e114.
Score: 0.057
-
Deep phenotyping of 34,128 adult patients hospitalised with COVID-19 in an international network study. Nat Commun. 2020 10 06; 11(1):5009.
Score: 0.057